Updated:
SINTEF
SINTEF er et av Europas største uavhengige forskningsinstitutter. Vi utfører flere tusen oppdrag hvert år – for små og store kunder.
SINTEF
SINTEF er et av Europas største uavhengige forskningsinstitutter. Vi utfører flere tusen oppdrag hvert år – for små og store kunder. SINTEF skal skape samfunnseffekt og levere verdensledende forskning for innovasjon.
General information
Firm type
Private Equity
Year founded
1950
AUM
Undisclosed
Location
Region
Europe
Country
Norway
City
Trondheim
Corporate office
Strindvegen 4, Trondheim, Norway
Additional offices
Oslo · Brussels · Bergen · Tromsø · Narvik · Mo i Rana · Steinkjer · Verdal · Ålesund · Raufoss · Kongsberg · Porsgrunn · Arendal · Hirtshals
Sector focus
Frequently asked questions
How does SINTEF source its investment portfolio?
SINTEF does not source deals in the traditional venture-capital sense. Portfolio companies emerge organically from technologies developed during its contract research assignments. The institute licenses its research results and forms new companies around them, then holds active ownership positions in those spin-offs. This means every portfolio company originates from SINTEF's own laboratories and the work of its 2,200 researchers.
Is SINTEF structured as a family office or does it operate more like a venture firm?
SINTEF is neither. It is an independent, non-profit research foundation that makes equity investments only in its own spin-off companies. The foundation operates on a contract-research model — over 90% of income comes from competitively won research assignments — and treats commercialization of its research outputs as part of its societal mandate rather than as a primary profit-seeking activity. Proceeds from sales of ownership interests are reinvested into scientific equipment, skills, and expertise.
What investment stages does SINTEF typically target?
SINTEF targets the earliest stage — pre-seed and seed at the point of company formation from its own research. SINTEF acts as the founding shareholder and provides follow-on support through growth stages as long as it remains an active shareholder. It does not invest in external startups, later-stage rounds, or companies without a direct lineage to its own research.
Which sectors does SINTEF explicitly avoid?
SINTEF's investment activity follows its research portfolio, so it is absent from consumer internet, financial technology, and other software-only venture categories that do not align with its laboratory-driven model. Its commercialization activity concentrates instead on deep-tech sectors — ocean space technologies, renewable energy systems, advanced materials, microsystems and nanotechnology, and health technologies — where physical laboratories and long-term research infrastructure provide a genuine competitive advantage.
How is SINTEF related to the Norwegian University of Science and Technology (NTNU)?
SINTEF was established in 1950 by NTH, the predecessor institution that is now part of NTNU. The two organizations maintain a formal partnership that includes joint operation of nearly 30 long-term research centers, shared use of about 200 laboratories, and extensive personnel overlap — NTNU staff work on SINTEF projects, and SINTEF researchers teach at NTNU. This creates a research-commercialization pipeline from academic discovery through to company formation without any formal MTA or tech-transfer office friction.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: